Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1203 - Catheter-free ambulatory pH test for gastroesophageal reflux disease (GORD)

The documents on this page may not be accessible, should you require assistance accessing the information please contact the MSAC Secretariat at msac.secretariat@health.gov.au
Application Number1203
Application NameCatheter-free ambulatory pH test for Gastroesophageal Reflux Disease (GORD)
Description of Medical ServiceThe Bravo pH Monitoring System is a catheter-free ambulatory pH test for gastroesophageal reflux disease (GORD). The Bravo pH Monitoring System utilizes a small pH capsule that is temporarily attached to the wall of the esophagus to transmit pH data for a minimum of 48 hours.
Description of Medical ConditionGORD occurs when reflux exposes the patient to the risk of physical complications or symptoms that would lead to a significant impairment of wellbeing or quality of life. Clinically significant impairment of wellbeing usually occurs when symptoms are present on two or more days of the week. Reflux carries the risk of reflux (peptic) esophagitis and complications such as Barrett esophagus and esophageal adenocarcinoma.
Consultation Protocol28 May 2012 – 5 July 2012
PDF version Consultation Decision Analytic Protocol (DAP) (PDF 459 KB)
Word version Consultation Decision Analytic Protocol (DAP) (Word 951 KB)
Final Protocol PDF version Final Decision Analytic Protocol (DAP) (PDF 214 KB)
Word version Final Decision Analytic Protocol (DAP) (Word 151 KB)
ReportsPDF Version Contracted Assessment Report (PDF 2059 KB)
Word Version Contracted Assessment Report (Word 1574 KB)
MSAC OutcomesPDF Version Public Summary Document (PDF 119 KB)
Word Version Public Summary Document (Word 142 KB)

Meetings for this Application

Meeting Type:Date:
PASC12 – 13 April 2012, 16 – 17 August 2012
ESC 13 – 14 February 2014
MSAC 3 - 4 April 2014

Page currency, Latest update: 16 April, 2015